Bryan Blair's questions to DONALDSON Co (DCI) leadership • Q4 2025
Question
Bryan Blair of Oppenheimer & Co. Inc. inquired about the agriculture market, asking for confirmation of a trough and the growth outlook. He also questioned the commercialization timeline for bioprocessing solutions in fiscal 2026 and the expected mix of first-fit versus aftermarket growth in the Industrial Solutions segment.
Answer
Chairman, CEO & President Tod Carpenter confirmed the agriculture market bottomed out during the quarter with low single-digit upticks against a low comparison point. He noted that significant revenue from new bioprocessing products is more likely in fiscal 2027, with current Life Sciences growth carried by traditional businesses. For Industrial Solutions, he and CFO Brad Pogalz highlighted that growth is primarily a replacement part story driven by share gains, with the outlook being broad-based across the segment's businesses.